Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TXMDTherapeuticsMD, Inc.

Nasdaq · CIK 0000025743
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts484

Identity from submissions API

NameTherapeuticsMD, Inc.
CIK0000025743
TickersTXMD
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN870233535
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone561-961-1900
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • AMHN, Inc. (2009-09-30T00:00:00.000Z → 2011-09-14T00:00:00.000Z)
  • CROFF ENTERPRISES INC (1997-11-17T00:00:00.000Z → 2009-09-04T00:00:00.000Z)
  • CROFF OIL CO (1995-10-03T00:00:00.000Z → 1997-04-01T00:00:00.000Z)
Business address
951 YAMATO ROAD, SUITE 220
BOCA RATON
FL
33431
FL
Mailing address
951 YAMATO ROAD, SUITE 220
BOCA RATON
FL
33431
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1181 filing rows loaded from submissions recent; extra archives: CIK0000025743-submissions-001.json (176 filings, 1995-08-16 to 2008-06-22).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 ARS ARS 0001213900-26-122702 001-00100 261579323 34 1015508
2026-11-20 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-122701 001-00100 261579307 34 3040867
2026-11-20 DEF 14A PROXY STATEMENT 0001213900-26-122695 001-00100 261579266 34 9667213 1 1
2026-11-13 10-Q QUARTERLY REPORT 0001213900-26-119697 001-00100 261552476 34 4487035 1 1
2026-11-13 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-119681 001-00100 261552386 34 233722 1 1
2026-08-11 10-Q QUARTERLY REPORT 0001213900-26-087768 001-00100 261263137 34 4344543 1 1
2026-08-11 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-087756 001-00100 261263017 34 234001 1 1
2026-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001957912-26-000027 005-32384 261244309 34 18012
2026-05-12 10-Q QUARTERLY REPORT 0001213900-26-055081 001-00100 26968781 34 4057593 1 1
2026-05-12 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-055070 001-00100 26968585 34 231919 1 1
2026-04-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-015371 005-32384 26842745 34 25671
2026-04-01 10-K/A ANNUAL REPORT 0001213900-26-037918 001-00100 26824444 34 6888161 1 1
2026-04-01 NT 10-K NOTIFICATION OF LATE FILING 0001213900-26-037914 001-00100 26824432 34 36461
2026-03-30 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-036519 001-00100 26814406 34 220421 1 1
2026-03-30 10-K ANNUAL REPORT 0001213900-26-036515 001-00100 26813912 34 8201161 1 1
2026-01-21 8-K CURRENT REPORT 4.01,9.01 0001213900-26-005779 001-00100 26544106 34 199628 1 1
2025-12-29 4 xslF345X05/form4.xml 0000905148-25-004488 5866
2025-12-16 8-K CURRENT REPORT 5.07 0001213900-25-122240 001-00100 251575077 34 220417 1 1
2025-11-13 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-109479 001-00100 251475079 34 218344 1 1
2025-11-12 10-Q QUARTERLY REPORT 0001213900-25-109381 001-00100 251474425 34 4340550 1 1
2025-11-05 4 xslF345X05/form4.xml 0000905148-25-003785 5228
2025-11-05 4 xslF345X05/form4.xml 0000905148-25-003784 5236
2025-11-05 4 xslF345X05/form4.xml 0000905148-25-003783 5206
2025-11-05 4 xslF345X05/form4.xml 0000905148-25-003782 5236
2025-11-03 ARS ARS 0001213900-25-105185 001-00100 251444014 34 515454
2025-11-03 DEFA14A PROXY STATEMENT 0001213900-25-105184 001-00100 251443992 34 3254822
2025-11-03 DEF 14A PROXY STATEMENT 0001213900-25-105183 001-00100 251443958 34 18949554 1 1
2025-10-24 PRE 14A PROXY STATEMENT 0001213900-25-102166 001-00100 251416213 34 19070725 1 1
2025-08-12 10-Q QUARTERLY REPORT 0001213900-25-075003 001-00100 251207301 34 4261569 1 1
2025-08-12 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-074975 001-00100 251206911 34 234086 1 1
2025-05-13 10-Q QUARTERLY REPORT 0001213900-25-042697 001-00100 25940813 34 4384384 1 1
2025-05-13 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-042663 001-00100 25940313 34 249272 1 1
2025-04-30 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-25-037713 001-00100 25896602 34 636565 1 1
2025-04-15 4 xslF345X05/form4.xml 0000905148-25-001216 6396
2025-04-15 4 xslF345X05/form4.xml 0000905148-25-001215 4418
2025-04-10 4 xslF345X05/form4.xml 0000905148-25-001190 6348
2025-04-09 8-K CURRENT REPORT 8.01 0001213900-25-030089 001-00100 25823784 34 196731 1 1
2025-03-27 10-K ANNUAL REPORT 0001013762-25-003442 001-00100 25780147 34 7175050 1 1
2025-03-27 8-K CURRENT REPORT 2.02,7.01,9.01 0001013762-25-003407 001-00100 25779907 34 231881 1 1
2025-02-20 4 xslF345X05/form4.xml 0000905148-25-000740 6729
2025-02-20 4 xslF345X05/form4.xml 0000905148-25-000739 6758
2025-02-20 4 xslF345X05/form4.xml 0000905148-25-000738 8219
2025-02-20 4 xslF345X05/form4.xml 0000905148-25-000737 17810
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001600136-25-000003 005-32384 25615200 34 13478
2024-12-05 8-K CURRENT REPORT 5.07 0001213900-24-106095 001-00100 241529885 34 213793 1 1
2024-11-12 SC 13G txmd.htm 0001600136-24-000007 005-32384 241449171 34 64543
2024-11-12 10-Q QUARTERLY REPORT 0001213900-24-096811 001-00100 241448440 34 4291789 1 1
2024-11-12 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-24-096804 001-00100 241448342 34 225946 1 1
2024-10-25 ARS FORM ARS 0001213900-24-090852 001-00100 241397770 34 546587
2024-10-25 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-090850 001-00100 241397756 34 3095102
2024-10-25 DEF 14A PROXY STATEMENT 0001213900-24-090849 001-00100 241397743 34 6135979
2024-09-20 8-K CURRENT REPORT 5.08 0001213900-24-080719 001-00100 241314014 34 202412 1 1
2024-08-26 4 xslF345X05/form4.xml 0000905148-24-002363 4914
2024-08-23 4 xslF345X05/form4.xml 0000905148-24-002340 4916
2024-08-12 10-Q QUARTERLY REPORT 0001213900-24-067771 001-00100 241197935 34 4139818 1 1
2024-08-12 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-24-067670 001-00100 241196852 34 224979 1 1
2024-06-14 AW AMENDMENT WITHDRAWAL REQUEST 0001213900-24-052954 333-253851 241045720 NE 13815
2024-05-10 10-Q QUARTERLY REPORT 0001213900-24-041738 001-00100 24935192 34 4006916 1 1
2024-05-10 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-24-041735 001-00100 24935065 34 229441 1 1
2024-04-29 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-24-037258 001-00100 24892272 34 680522 1 1
2024-03-29 10-K ANNUAL REPORT 0001213900-24-028003 001-00100 24804473 34 7112905 1 1
2024-03-29 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-24-027998 001-00100 24804410 34 240518 1 1
2023-12-07 4 FORM 4 SUBMISSION 0001209191-23-057725 11479
2023-12-06 144 xsl144X01/primary_doc.xml 0001974078-23-000264 001-00100 231468787 33 4426
2023-11-17 SC 13D/A SC 13D/A 0001104659-23-119332 005-32384 231416752 34 55769
2023-11-17 4 OWNERSHIP DOCUMENT 0001104659-23-119331 8138
2023-11-14 10-Q FORM 10-Q 0001193125-23-277143 001-00100 231407029 34 5943976 1 1
2023-11-14 8-K 8-K 2.02,7.01,9.01 0001193125-23-277136 001-00100 231406834 34 173313 1 1
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046702 5156
2023-08-21 3 FORM 3 SUBMISSION 0001209191-23-046701 3148
2023-08-18 8-K 8-K 1.01,5.02 0001193125-23-216056 001-00100 231186728 34 148623 1 1
2023-08-14 10-Q FORM 10-Q 0001193125-23-211458 001-00100 231166270 34 5717098 1 1
2023-08-14 8-K FORM 8-K 2.02,7.01,9.01 0001193125-23-211446 001-00100 231166211 34 169264 1 1
2023-07-19 4 FORM 4 SUBMISSION 0001209191-23-042767 5512
2023-07-19 4 FORM 4 SUBMISSION 0001209191-23-042765 5550
2023-07-19 4 FORM 4 SUBMISSION 0001209191-23-042763 5521
2023-07-11 D xslFormDX01/primary_doc.xml 06b 0000025743-23-000001 021-486406 231080732 33 10480
2023-07-10 8-K FORM 8-K 4.01,9.01 0001193125-23-184765 001-00100 231080599 34 159750 1 1
2023-07-06 8-K FORM 8-K 3.02,5.03,9.01 0001193125-23-182808 001-00100 231074110 34 159397 1 1
2023-06-30 SC 13D/A SC 13D/A 0001104659-23-076713 005-32384 231059602 34 56824
2023-06-29 4 OWNERSHIP DOCUMENT 0001104659-23-076387 8122
2023-06-28 8-K FORM 8-K 5.07 0001193125-23-176709 001-00100 231049159 34 161436 1 1
2023-05-18 ARS ARS 0001193125-23-147186 001-00100 23933114 34 107314321
2023-05-17 DEFA14A DEFA14A 0001193125-23-147110 001-00100 23932693 34 1014685
2023-05-17 DEF 14A DEF 14A 0001193125-23-147098 001-00100 23932624 34 2788004
2023-05-15 10-Q 10-Q 0001193125-23-145064 001-00100 23922934 34 5172583 1 1
2023-05-15 8-K 8-K 2.02,7.01,9.01 0001193125-23-145019 001-00100 23922600 34 168424 1 1
2023-05-05 8-K 8-K 1.01 0001193125-23-137263 001-00100 23895106 34 147810 1 1
2023-05-04 4/A FORM 4/A SUBMISSION 0001209191-23-027361 13299
2023-05-01 PRE 14A PRE 14A 0001193125-23-130668 001-00100 23874877 34 2684003
2023-05-01 10-K/A FORM 10-K/A 0001193125-23-130656 001-00100 23874817 34 702169 1 1
2023-04-21 8-K 8-K 8.01 0001193125-23-110686 001-00100 23837244 34 151775 1 1
2023-04-14 4 FORM 4 SUBMISSION 0001209191-23-024388 21755
2023-04-14 4 FORM 4 SUBMISSION 0001209191-23-024386 7626
2023-04-07 10-K 10-K 0001564590-23-005514 001-00100 23809102 34 16344861 1 1
2023-04-07 8-K 8-K 2.02,7.01,9.01 0001193125-23-095317 001-00100 23809075 34 184615 1 1
2023-03-31 NT 10-K NT 10-K 0001193125-23-088302 001-00100 23788969 34 24557
2023-02-27 8-K 8-K 5.02,9.01 0001193125-23-050813 001-00100 23675334 34 305528 1 1
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012287 5605
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012271 5638
2023-02-22 4/A FORM 4/A 0001104659-23-024323 8480
2023-02-13 5 FORM 5 SUBMISSION 0001209191-23-008817 4972
2023-01-30 4 FORM 4 SUBMISSION 0001209191-23-005554 18870
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004871 23709
2023-01-18 8-K 8-K 5.02 0001193125-23-010258 001-00100 23535015 34 145472 1 1
2023-01-12 8-K 8-K 3.01 0001193125-23-007281 001-00100 23526504 34 143421 1 1
2023-01-06 8-K/A 8-K/A 5.02,9.01 0001193125-23-003686 001-00100 23516050 34 379749 1 1
2023-01-03 4 OWNERSHIP DOCUMENT 0001104659-23-000311 7416
2023-01-03 8-K FORM 8-K 1.01,1.02,2.01,5.02,7.01,8.01,9.01 0001193125-23-000222 001-00100 23500170 34 188924 1 1
2022-12-12 4 OWNERSHIP DOCUMENT 0001104659-22-126117 7965
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060588 14206
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060587 17540
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060586 9327
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060585 21514
2022-12-09 4 OWNERSHIP DOCUMENT 0001104659-22-125712 10131
2022-12-08 4 FORM 4 SUBMISSION 0001209191-22-060424 5209
2022-12-05 8-K FORM 8-K 1.01,7.01,9.01 0001193125-22-298002 001-00100 221443755 34 3546587 1 1
2022-12-01 8-K 8-K 1.01 0001193125-22-296035 001-00100 221437574 34 150066 1 1
2022-11-14 10-Q 10-Q 0001564590-22-037666 001-00100 221387304 34 11110656 1 1
2022-11-14 D xslFormDX01/primary_doc.xml 06b 0000025743-22-000002 021-464765 221386989 33 16208
2022-11-14 8-K 8-K 2.02,7.01,9.01 0001564590-22-037633 001-00100 221386072 34 819244 1 1
2022-10-31 4 OWNERSHIP DOCUMENT 0001104659-22-112801 7423
2022-10-31 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001193125-22-273110 001-00100 221343774 34 625986 1 1
2022-10-17 D xslFormDX01/primary_doc.xml 06b 0000025743-22-000001 021-462011 221314066 33 16208
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051961 5525
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051952 5378
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051962 5489
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051955 5495
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051960 5525
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051958 5491
2022-10-03 4 FORM 4 SUBMISSION 0001209191-22-051957 5513
2022-10-03 4 OWNERSHIP DOCUMENT 0001104659-22-105392 7423
2022-10-03 8-K FORM 8-K 1.01,3.02,7.01,9.01 0001193125-22-256102 001-00100 221285912 34 611975 1 1
2022-09-16 3 FORM 3 SUBMISSION 0001209191-22-050344 16877
2022-09-12 8-K 8-K 5.02,7.01,9.01 0001193125-22-242398 001-00100 221237355 34 170679 1 1
2022-08-31 3 FORM 3 SUBMISSION 0001209191-22-048163 3128
2022-08-30 SC 13D/A SC 13D/A 0001104659-22-095856 005-32384 221213007 34 38181
2022-08-29 8-K 8-K 5.02 0001193125-22-232894 001-00100 221211881 34 145776 1 1
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046969 7444
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046968 7472
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046967 7439
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046966 7473
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046965 7461
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046964 8933
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046963 7326
2022-08-16 D xslFormDX01/primary_doc.xml 06b 0001209191-22-045903 021-456038 221168091 33 15451
2022-08-15 10-Q 10-Q 0001564590-22-029490 001-00100 221165926 34 10203687 1 1
2022-08-15 8-K 8-K 2.02,7.01,9.01 0001564590-22-029394 001-00100 221162302 34 4043632 1 1
2022-08-08 SC 13D SC 13D 0001104659-22-087294 005-32384 221145042 34 80123
2022-08-01 4 OWNERSHIP DOCUMENT 0001104659-22-084850 9122
2022-08-01 8-K FORM 8-K 1.01,3.02,3.03,5.03,7.01,9.01 0001193125-22-207645 001-00100 221122701 34 816153 1 1
2022-07-29 8-K 8-K 1.01 0001193125-22-205794 001-00100 221117629 34 148667 1 1
2022-07-28 8-K 8-K 1.01,9.01 0001193125-22-204332 001-00100 221113131 34 151051 1 1
2022-07-25 8-K 8-K 1.01,8.01 0001193125-22-200476 001-00100 221101264 34 150568 1 1
2022-07-19 4 OWNERSHIP DOCUMENT 0001104659-22-080754 10124
2022-07-19 3 OWNERSHIP DOCUMENT 0001104659-22-080751 7764
2022-07-14 8-K 8-K 1.01,1.02,9.01 0001193125-22-193376 001-00100 221082272 34 153588 1 1
2022-07-13 SC 14D9/A SC 14D9/A 0001193125-22-192325 005-32384 221080208 34 75577
2022-07-13 SC TO-T/A SC TO-T/A 0001193125-22-192255 005-32384 221080137 34 35222
2022-07-08 SC 13G/A us88338n2062_071122.txt 0000834237-22-010168 005-32384 221074890 34 12425
2022-07-06 SC 14D9/A SC 14D9/A 0001193125-22-188208 005-32384 221067374 34 21314
2022-07-06 SC TO-T/A SC TO-T/A 0001193125-22-188203 005-32384 221067359 34 55900
2022-06-28 SC 14D9/A SC 14D9/A 0001193125-22-183959 005-32384 221050553 34 143424
2022-06-23 SC TO-T/A SC TO-T/A 0001193125-22-180056 005-32384 221035494 34 49517
2022-06-13 SC 14D9 SC 14D9 0001193125-22-172146 005-32384 221010297 34 614764
2022-06-06 SC TO-T SC TO-T 0001193125-22-168449 005-32384 22998780 34 1371729
2022-06-06 8-K/A 8-K/A 5.03,9.01 0001564590-22-022527 001-00100 22996625 34 183524 1 1
2022-06-03 SC 13G txmd13g.htm 0000935836-22-000362 005-32384 22995163 34 69624
2022-06-03 8-K 8-K 1.01,9.01 0001564590-22-022465 001-00100 22994994 34 174773 1 1
2022-05-31 SC TO-C SC TO-C 0001193125-22-162948 005-32384 22980998 34 47746
2022-05-31 SC14D9C SC14D9C 0001193125-22-163068 005-32384 22980506 34 40075
2022-05-31 8-K 8-K 1.01,8.01,9.01 0001564590-22-021755 001-00100 22980376 34 4685271 1 1
2022-05-20 8-K 8-K 7.01,8.01,9.01 0001564590-22-020824 001-00100 22946089 34 190961 1 1
2022-05-16 10-Q 10-Q 0001564590-22-020440 001-00100 22930639 34 8221199 1 1
2022-05-16 8-K 8-K 2.02,7.01,9.01 0001564590-22-020389 001-00100 22928994 34 3265512 1 1
2022-05-09 8-K 8-K 3.03,5.03,9.01 0001564590-22-018687 001-00100 22903155 34 235875 1 1
2022-04-29 10-K/A 10-K/A 0001564590-22-016823 001-00100 22876008 34 1624209 1 1
2022-04-27 8-K 8-K 8.01 0001564590-22-016083 001-00100 22860104 34 164035 1 1
2022-04-20 8-K 8-K 2.01,2.04,9.01 0001564590-22-014927 001-00100 22838279 34 527978 1 1
2022-04-14 8-K 8-K 7.01,9.01 0001564590-22-014472 001-00100 22827598 34 193192 1 1
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021795 6014
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021794 6039
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021793 6057
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021792 6046
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021212 5721
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021211 5703
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021210 5678
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021209 5710
2022-03-28 4 FORM 4 SUBMISSION 0001209191-22-021208 5678
2022-03-24 POS AM POS AM 0001193125-22-082932 333-253851 22764121 33 737911
2022-03-23 10-K 10-K 0001564590-22-011525 001-00100 22763731 34 16635880 1 1
2022-03-23 POSASR POSASR 0001193125-22-082798 333-253851 22763619 33 949950
2022-03-23 SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-22-003889 005-32384 22763396 34 92724
2022-03-18 8-K 8-K 3.01,5.02 0001564590-22-011090 001-00100 22753271 34 166902 1 1
2022-03-15 4 FORM 4 SUBMISSION 0001209191-22-018682 7439
2022-03-10 8-K 8-K 1.01,2.02,7.01,9.01 0001564590-22-009476 001-00100 22727386 34 5994422 1 1
2022-03-07 8-K 8-K 7.01,9.01 0001564590-22-008860 001-00100 22716282 34 194510 1 1
2022-02-18 8-K 8-K 5.02 0001564590-22-005710 001-00100 22653263 34 157123 1 1
2022-02-14 SC 13G/A txmd13gadec21.txt 0000080255-22-002012 005-32384 34 7252
2022-02-01 SC 13G/A us88338n1072_013122.txt 0000834237-22-003903 005-32384 22575626 34 13423
2022-01-03 8-K 8-K 8.01 0001564590-22-000008 001-00100 22500068 34 163452 1 1
2021-12-20 8-K 8-K 5.02 0001564590-21-060676 001-00100 211503729 34 159597 1 1
2021-12-17 8-K 8-K 5.02 0001564590-21-060654 001-00100 211502374 34 157406 1 1
2021-12-10 8-K 8-K 7.01,8.01,9.01 0001564590-21-060036 001-00100 211486060 34 200651 1 1
2021-12-08 8-K 8-K 7.01,8.01,9.01 0001564590-21-059685 001-00100 211477611 34 194526 1 1
2021-12-02 4 FORM 4 SUBMISSION 0001209191-21-067391 9897
2021-11-22 4 FORM 4 SUBMISSION 0001209191-21-066002 5245
2021-11-16 8-K/A 8-K/A 2.02,7.01,9.01 0001564590-21-057142 001-00100 211414056 34 287588 1 1
2021-11-12 10-Q 10-Q 0001564590-21-056434 001-00100 211399426 34 10029139 1 1
2021-11-12 8-K 8-K 2.02,5.02,7.01,9.01 0001564590-21-056427 001-00100 211399399 34 4626205 1 1
2021-10-15 4 FORM 4 SUBMISSION 0001209191-21-060610 11576
2021-10-15 3 FORM 3 SUBMISSION 0001209191-21-060607 3180
2021-10-15 S-8 S-8 0001564590-21-050961 333-260295 211326581 33 342401
2021-10-01 SC TO-I/A SC TO-I/A 0001193125-21-289853 005-32384 211299868 34 25358
2021-10-01 8-K 8-K 5.02 0001564590-21-049852 001-00100 211299753 34 158008 1 1
2021-10-01 4 FORM 4 SUBMISSION 0001209191-21-058493 16452
2021-10-01 4 FORM 4 SUBMISSION 0001209191-21-058498 16466
2021-09-17 8-K 8-K 3.01 0001564590-21-048250 001-00100 211261139 34 160680 1 1
2021-09-07 8-K 8-K 8.01 0001564590-21-047142 001-00100 211238221 34 164136 1 1
2021-08-31 4 FORM 4 SUBMISSION 0001209191-21-054119 8752
2021-08-31 S-8 S-8 HUGH O'DOWD INDUCEMENT GRANT 0001564590-21-046622 333-259221 211227863 33 195064
2021-08-30 SC TO-I/A SC TO-I/A 0001193125-21-260770 005-32384 211224301 34 31989
2021-08-26 SC TO-I SC TO-I 0001193125-21-257695 005-32384 211213071 34 400315
2021-08-19 4 xslF345X03/ownership.xml 0001387131-21-008750 5235
2021-08-19 4 xslF345X03/ownership.xml 0001387131-21-008733 7281
2021-08-18 4 xslF345X03/ownership.xml 0001387131-21-008680 5099
2021-08-17 4 xslF345X03/ownership.xml 0001387131-21-008639 6437
2021-08-13 3 xslF345X02/ownership.xml 0001387131-21-008528 3101
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008441 7409
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008440 7413
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008439 7263
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008438 7379
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008437 9725
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008436 7384
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008435 9188
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008434 7409
2021-08-12 4 xslF345X03/ownership.xml 0001387131-21-008433 7397
2021-08-09 8-K 8-K 5.02,7.01,9.01 0001564590-21-042695 001-00100 211157028 34 502513 1 1
2021-08-04 10-Q 10-Q 0001564590-21-040907 001-00100 211144884 34 9111077 1 1
2021-08-04 8-K 8-K 2.02,7.01,9.01 0001564590-21-040490 001-00100 211142293 34 6432459 1 1
2021-07-07 SC 13G e620777_sc13g-therapeuticsmd.htm 0001193805-21-000985 005-32384 211077123 34 100336
2021-07-02 4 FORM 4 - LING 0001387131-21-007139 5498
2021-07-02 4 FORM 4 - CARROLL 0001387131-21-007137 5484
2021-07-02 4 FORM 4 - MUSING 0001387131-21-007135 5481
2021-07-02 4 FORM 4 - RUSSELL 0001387131-21-007133 5516
2021-07-02 4 FORM 4 - NAUGHTON 0001387131-21-007131 5514
2021-07-02 4 FORM 4 - BISARO 0001387131-21-007129 5365
2021-07-02 4 FORM 4 - COLLINS 0001387131-21-007127 5486
2021-07-02 4 FORM 4 - THOMPSON 0001387131-21-007125 5481
2021-07-02 4 FORM 4 - FINIZIO 0001387131-21-007122 8771
2021-07-02 4 FORM 4 - BORKOWSKI 0001387131-21-007119 8774
2021-07-02 4 FORM 4 - WALKER 0001387131-21-007117 8764
2021-07-02 4 FORM 4 - D'ARECCA 0001387131-21-007115 8734
2021-07-02 4 FORM 4 - DONEGAN 0001387131-21-007114 8791
2021-06-08 S-8 FORM S-8 0001193125-21-184760 333-256879 211001009 33 70307
2021-05-28 8-K 8-K 5.02,5.07,9.01 0001193125-21-177164 001-00100 21981390 34 177420 1 1
2021-05-21 DEFA14A DEFA14A 0001193125-21-169441 001-00100 21950240 34 21809
2021-05-18 4 xslF345X03/ownership.xml 0001387131-21-005770 7014
2021-05-12 4 FORM 4 - DONEGAN 0001387131-21-005571 9738
2021-05-12 4 FORM 4 - WALKER 0001387131-21-005570 9710
2021-05-12 4 FORM 4 - BORKOWSKI 0001387131-21-005568 9158
2021-05-12 4 FORM 4 - MILLIGAN 0001387131-21-005567 10048
2021-05-12 4 FORM 4 - FINIZIO 0001387131-21-005565 9999
2021-05-06 10-Q 10-Q 0001193125-21-153419 001-00100 21898714 34 4567647 1 1
2021-05-06 8-K 8-K 2.02,7.01,9.01 0001193125-21-152445 001-00100 21895703 34 11910297 1 1
2021-04-19 SEC STAFF LETTER filename1.pdf 9999999997-21-001359 411923
2021-04-14 DEFA14A DEFA14A 0001193125-21-116481 001-00100 21826439 34 182555
2021-04-14 DEF 14A DEF 14A 0001193125-21-116458 001-00100 21826416 34 3175709
2021-04-12 8-K CURRENT REPORT 5.02,9.01 0001387131-21-004324 001-00100 21819318 34 221989 1 1
2021-04-01 PRE 14A PRE 14A 0001193125-21-104039 001-00100 21798496 34 3101714
2021-03-22 SEC STAFF LETTER filename1.pdf 9999999997-21-000623 422452
2021-03-08 4 FORM 4 - FINIZIO 0001387131-21-003349 12928
2021-03-08 4 FORM 4 - MILLIGAN 0001387131-21-003348 11931
2021-03-04 S-3ASR S-3ASR 0001193125-21-068004 333-253851 21711844 33 1113745
2021-03-04 10-K ANNUAL REPORT 0001387131-21-003140 001-00100 21711765 34 12154430 1 1
2021-03-02 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-21-003075 001-00100 21701258 34 6695304 1 1
2021-02-16 SC 13G/A txmd13gadec20.txt 0000080255-21-001115 005-32384 34 7064
2021-02-16 8-K CURRENT REPORT 1.01,9.01 0001387131-21-002393 001-00100 21632869 34 511901 1 1
2021-02-16 424B2 FORM 424(B)(2) 0001193125-21-043159 333-226452 21631962 33 659866
2021-02-10 424B5 424B5 0001193125-21-036460 333-226452 21615017 33 663754
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-019226 005-32384 21612144 34 14081
2021-02-08 SC 13G/A filing.txt 0000315066-21-001269 005-32384 21599813 34 8731
2021-02-01 SC 13G/A us88338n1072_013121.txt 0000834237-21-005630 005-32384 21574619 34 13581
2021-01-13 8-K CURRENT REPORT 1.01,7.01,9.01 0001387131-21-000535 001-00100 21525134 34 11368527 1 1
2020-12-09 SC 13G/A FILING THERAPEUTICSMD, INC. 0000019617-20-000526 005-32384 34 90045
2020-11-27 4 FORM 4 - DONEGAN 0001387131-20-010309 5604
2020-11-27 4 FORM 4 - MILLIGAN 0001387131-20-010306 5604
2020-11-27 4 FORM 4 - FINIZIO 0001387131-20-010304 5506
2020-11-27 424B5 424B5 0001193125-20-304588 333-226452 201355622 33 786614
2020-11-27 8-K CURRENT REPORT 1.01,5.02,9.01 0001387131-20-010302 001-00100 201355548 34 1072105 1 1
2020-11-13 8-K 8-K 1.01,9.01 0001193125-20-291974 001-00100 201308893 34 374472 1 1
2020-11-12 424B2 424B2 0001193125-20-291820 333-226452 201308029 33 550183
2020-11-09 424B5 424B5 0001193125-20-289241 333-226452 201298843 33 553255
2020-11-09 10-Q QUARTERLY REPORT 0001387131-20-009695 001-00100 201296364 34 6504398 1 1
2020-11-09 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-20-009685 001-00100 201296032 34 8498050 1 1
2020-09-14 8-K CURRENT REPORT 7.01,9.01 0001387131-20-008293 001-00100 201172231 34 11001480 1 1
2020-08-14 D xslFormDX01/primary_doc.xml 06b 0001387131-20-007573 021-373323 201106679 33 16433
2020-08-07 4/A OWNERSHIP DOCUMENT 0001387131-20-007227 8806
2020-08-07 3 OWNERSHIP DOCUMENT 0001387131-20-007225 8713
2020-08-07 3 OWNERSHIP DOCUMENT 0001387131-20-007223 20459
2020-08-07 S-8 INITIAL REGISTRATION STATEMENT 0001387131-20-007210 333-242363 201085534 33 90976
2020-08-07 10-Q CURRENT REPORT 0001387131-20-007144 001-00100 201083234 34 7148039 1 1
2020-08-06 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-20-007080 001-00100 201079713 34 4885755 1 1
2020-06-23 8-K CURRENT REPORT 7.01,9.01 0001387131-20-005881 001-00100 20980262 34 6840086 1 1
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005822 5368
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005821 5482
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005820 5518
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005819 5515
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005818 5484
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005817 5503
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005816 5488
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005815 5486
2020-06-19 4 OWNERSHIP DOCUMENT 0001387131-20-005814 8349
2020-06-18 8-K CURRENT REPORT 5.02,5.07,9.01 0001387131-20-005767 001-00100 20972830 34 261290 1 1
2020-06-10 4 xslF345X03/ownership.xml 0001387131-20-005591 6087
2020-06-10 4 xslF345X03/ownership.xml 0001387131-20-005580 8420
2020-06-08 4 OWNERSHIP DOCUMENT 0001387131-20-005525 6473
2020-06-08 4 xslF345X03/ownership.xml 0001387131-20-005523 4486
2020-06-08 4 OWNERSHIP DOCUMENT 0001387131-20-005521 9017
2020-06-04 3 xslF345X02/ownership.xml 0001387131-20-005478 3079
2020-06-01 8-K CURRENT REPORT 5.02,7.01,9.01 0001387131-20-005353 001-00100 20930872 34 238819 1 1
2020-05-15 8-K CURRENT REPORT 1.02,8.01 0001387131-20-004921 001-00100 20886560 34 210980 1 1
2020-05-13 8-K CURRENT REPORT 7.01,9.01 0001387131-20-004678 001-00100 20871012 34 6234023 1 1
2020-05-06 10-Q QUARTERLY REPORT 0001387131-20-004479 001-00100 20853706 34 5292702 1 1
2020-05-06 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-20-004451 001-00100 20851067 34 5477438 1 1
2020-05-05 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-20-046605,2020-05-05 9999999995-20-001030 333-226452 20850960 33 1964
2020-05-04 DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS 0001387131-20-004411 001-00100 20845729 34 54716
2020-05-04 DEF 14A DEFINITIVE PROXY STATEMENT 0001387131-20-004409 001-00100 20845695 34 1193534
2020-05-01 8-K CURRENT REPORT 1.01,2.03 0001387131-20-004356 001-00100 20841773 34 215415 1 1
2020-04-29 10-K/A AMENDED 10-K 0001387131-20-004224 001-00100 20827101 34 784004 1 1
2020-04-22 3 OWNERSHIP DOCUMENT 0001387131-20-004068 3174
2020-04-22 PRER14A PRELIMINARY REVISED PROXY SOLICITING MATERIALS 0001387131-20-004066 001-00100 20808531 34 1235562
2020-04-22 8-K CURRENT REPORT 5.02,7.01,8.01,9.01 0001387131-20-004062 001-00100 20808478 34 249358 1 1
2020-04-13 PRE 14A PRELIMINARY PROXY STATEMENT 0001387131-20-003861 001-00100 20789358 34 1188501
2020-04-01 4 FORM 4 - MILLIGAN 0001387131-20-003593 8671
2020-04-01 4 FORM 4 - FINIZIO 0001387131-20-003592 8638
2020-04-01 4 FORM 4 - KRASSAN 0001387131-20-003591 8656
2020-04-01 4 FORM 4 - CARTWRIGHT 0001387131-20-003590 8673
2020-04-01 4 FORM 4 - DONEGAN 0001387131-20-003589 8662
2020-03-26 3 xslF345X02/naughton-form4_032020.xml 0001387131-20-003284 3106
2020-03-26 3 xslF345X02/bisaro-form4_032020.xml 0001387131-20-003282 2957
2020-03-26 8-K CURRENT REPORT 7.01,8.01,9.01 0001387131-20-003271 001-00100 20746205 34 260323 1 1
2020-03-24 8-K CURRENT REPORT 5.02,7.01,9.01 0001387131-20-003130 001-00100 20736629 34 272802 1 1
2020-03-05 SEC STAFF LETTER filename1.pdf 9999999997-20-001150 354795
2020-03-03 8-K CURRENT REPORT 7.01,9.01 0001387131-20-002411 001-00100 20679917 34 8216803 1 1
2020-02-24 POS AM POS AM 0001193125-20-046605 333-226452 20645129 33 483316
2020-02-24 10-K ANNUAL REPORT 0001387131-20-002086 001-00100 20644527 34 9424205 1 1
2020-02-24 POSASR POSASR 0001193125-20-046336 333-226452 20644381 33 533048
2020-02-20 8-K CURRENT REPORT 2.02,2.03,7.01,9.01 0001387131-20-001953 001-00100 20632508 34 5843696 1 1
2020-02-14 SC 13G/A txmd13gadec19.txt 0000080255-20-001136 005-32384 34 7054
2020-02-12 SC 13G/A SCHEDULE 13G/A 0001104659-20-018756 005-32384 20601787 34 13905
2020-02-07 SC 13G/A filing.txt 0000315066-20-001245 005-32384 20585962 34 8613
2020-02-06 SC 13G/A us88338n1072_020520.txt 0000834237-20-006840 005-32384 20581335 34 13584
2020-02-05 4 OWNERSHIP DOCUMENT 0001387131-20-001050 12884
2020-02-04 SEC STAFF LETTER filename1.pdf 9999999997-20-000456 359441
2020-01-21 SC 13G/A FILING THERAPEUTICSMD, INC. 0000019617-20-000126 005-32384 34 90089
2020-01-14 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-20-000236 001-00100 20524938 34 8169373 1 1
2019-12-30 8-K CURRENT REPORT 1.01,7.01,9.01 0001387131-19-009918 001-00100 191314752 34 240995 1 1
2019-12-18 8-K CURRENT REPORT 7.01,9.01 0001387131-19-009657 001-00100 191293390 34 1829349 1 1
2019-12-10 SC 13G/A Therapeuticsmd_13G_Filing_A.txt 0001390777-19-000118 005-32384 191277465 34 50610
2019-11-19 8-K CURRENT REPORT 7.01,9.01 0001387131-19-008853 001-00100 191229012 34 21027459 1 1
2019-11-08 10-Q QUARTERLY REPORT 0001387131-19-008469 001-00100 191204276 34 6154057 1 1
2019-11-06 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-19-008376 001-00100 191196356 34 9990464 1 1
2019-10-29 4 OWNERSHIP DOCUMENT 0001387131-19-007990 6938
2019-10-29 4 OWNERSHIP DOCUMENT 0001387131-19-007992 6938
2019-10-29 4 OWNERSHIP DOCUMENT 0001387131-19-007989 7454
2019-10-29 4 OWNERSHIP DOCUMENT 0001387131-19-007988 6571
2019-10-29 8-K 8-K 1.01,9.01 0001193125-19-277097 001-00100 191174589 34 384822 1 1
2019-10-25 424B2 424B2 0001193125-19-274826 333-226452 191170427 33 655228
2019-10-24 FWP FWP 0001193125-19-272880 333-226452 191164700 34 14961116
2019-10-23 8-K 8-K 2.02,7.01,9.01 0001193125-19-272703 001-00100 191164447 34 175906 1 1
2019-10-23 FWP FWP 0001193125-19-272683 333-226452 191164404 34 21822
2019-10-23 424B5 424B5 0001193125-19-272677 333-226452 191164402 33 650815
2019-10-15 8-K CURRENT REPORT 7.01,9.01 0001387131-19-007619 001-00100 191149099 34 2456333 1 1
2019-10-01 8-K CURRENT REPORT 7.01,9.01 0001387131-19-007303 001-00100 191127551 34 18834516 1 1
2019-09-25 8-K CURRENT REPORT 7.01,9.01 0001387131-19-007118 001-00100 191111996 34 3469872 1 1
2019-09-16 8-K CURRENT REPORT 7.01,9.01 0001387131-19-006944 001-00100 191093709 34 14900550 1 1
2019-09-10 SC 13G/A TherapeuticsMD_13G_Filing.txt 0001390777-19-000099 005-32384 191085204 34 51677
2019-08-30 4 OWNERSHIP DOCUMENT 0001387131-19-006607 5748
2019-08-30 4 OWNERSHIP DOCUMENT 0001387131-19-006606 5740
2019-08-30 4 xslF345X03/ownership.xml 0001387131-19-006605 5719
2019-08-30 4 xslF345X03/ownership.xml 0001387131-19-006604 5676
2019-08-30 4 OWNERSHIP DOCUMENT 0001387131-19-006603 5379
2019-08-30 4 xslF345X03/ownership.xml 0001387131-19-006602 5715
2019-08-26 4 xslF345X03/ownership.xml 0001387131-19-006399 5302
2019-08-20 4 OWNERSHIP DOCUMENT 0001387131-19-006289 7037
2019-08-19 4 xslF345X03/ownership.xml 0001387131-19-006246 7369
2019-08-15 4 OWNERSHIP DOCUMENT 0001387131-19-006191 7376
2019-08-14 4 OWNERSHIP DOCUMENT 0001387131-19-006151 5306
2019-08-14 4 OWNERSHIP DOCUMENT 0001387131-19-006150 7400
2019-08-13 4 OWNERSHIP DOCUMENT 0001387131-19-006036 6550
2019-08-13 4 OWNERSHIP DOCUMENT 0001387131-19-006033 7933
2019-08-12 4 OWNERSHIP DOCUMENT 0001387131-19-006018 8735
2019-08-09 10-Q QUARTERLY REPORT 0001387131-19-005935 001-00100 191012698 34 8324542 1 1
2019-08-06 8-K CURRENT REPORT 2.02,7.01,9.01 0001387131-19-005793 001-00100 191002120 34 10545001
2019-07-09 8-K CURRENT REPORT 7.01,9.01 0001387131-19-004898 001-00100 19946325 34 21146601
2019-06-24 4 OWNERSHIP DOCUMENT 0001387131-19-004590 5365
2019-06-24 4 OWNERSHIP DOCUMENT 0001387131-19-004589 5376
2019-06-24 4 OWNERSHIP DOCUMENT 0001387131-19-004588 5402
2019-06-24 4 OWNERSHIP DOCUMENT 0001387131-19-004587 5367

Latest XBRL company facts

One latest value per concept from companyfacts (484 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 11.57M 2026-11-09 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
dei EntityPublicFloat Entity Public Float USD 9.04M 2025-06-30 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 120,000 2025-01-01 2025-12-31 DEF 14A 2026-11-20 0001213900-26-122695
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 120,000 2025-01-01 2025-12-31 DEF 14A 2026-11-20 0001213900-26-122695
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 792,235 2025-01-01 2025-12-31 DEF 14A 2026-11-20 0001213900-26-122695
ecd PeoTotalCompAmt PeoTotalCompAmt USD 811,137 2025-01-01 2025-12-31 DEF 14A 2026-11-20 0001213900-26-122695
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 9.06 2025-01-01 2025-12-31 DEF 14A 2026-11-20 0001213900-26-122695
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 35,240 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 1.21M 2015-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 2.21M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 377,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 243,000 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 32.16M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap AccountsReceivableRelatedParties Accounts Receivable, Related Parties USD 0 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 290,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 2.21M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AccruedMarketingCostsCurrent Accrued Marketing Costs, Current USD 3.48M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 282,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AccruedRentCurrent Accrued Rent, Current USD 365,155 2018-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 114,480 2017-12-31 2018 FY 10-K 2019-02-27 0001387131-19-001471
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 8.76M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap AccruedSalesCommissionCurrent Accrued Sales Commission, Current USD 112,000 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 2.35M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.52M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap AcquisitionCostsCumulative Acquisition Costs, Cumulative USD 2.33M 2025-06-30 2025 Q2 10-Q 2025-08-12 0001213900-25-075003
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 979.12M 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 979.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AdjustmentForAmortization Amortization USD 1.50M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-07 0001387131-20-007144
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 6.72M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 867,262 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001387131-16-004361
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 3.25M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-05 0001387131-14-000771
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 233,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 264,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 7.67M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-23 0001564590-22-011525
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD 2.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AdvertisingExpense Advertising Expense USD 13.20M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 1.62M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 764,102 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 181,514 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 255,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 1.10M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001387131-16-004361
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 260,027 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-28 0001387131-17-001111
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 2.26M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 159,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AreaOfLand Area of Land sqm 6,536 2020-05-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 1.26M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap Assets Assets USD 37.93M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AssetsCurrent Assets, Current USD 17.42M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap AssetsNoncurrent Assets, Noncurrent USD 55.86M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001387131-19-008469
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 344,000 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 344,000 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Assets of Disposal Group, Including Discontinued Operation, Noncurrent (Deprecated 2014-01-31) USD 466,172 2010-12-31 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables USD 29.30M 2022-12-30 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory USD 8.40M 2022-12-30 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap Cash Cash USD 4.33M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 2,844 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 5.75M 2025-03-31 2025 Q1 10-Q 2025-05-13 0001213900-25-042697
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 10.45M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations USD 215,000 2021-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 4.33M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 10.45M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD 21.23M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations Cash Provided by (Used in) Financing Activities, Discontinued Operations USD 1.11M 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations Cash Provided by (Used in) Investing Activities, Discontinued Operations USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.13 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 6.53M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 12.19M 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 640.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 11.57M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 11.57M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 8.36M 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap CommonStockValue Common Stock, Value, Issued USD 11,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -10.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 0.6 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 17.24M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1.40M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 633,623 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001387131-18-001945
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.05M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 2.78M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 1.05M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD -6.72M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.38 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 75.00M 2019-03-31 2019 Q1 10-Q 2019-05-08 0001387131-19-003457
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.125 2020-09-30 2020 Q3 10-Q 2020-11-09 0001387131-20-009695
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.06 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 7.63M 2020-03-31 2020 Q1 10-Q 2020-05-06 0001387131-20-004479
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 12.30M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 260,027 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-07 0001387131-14-003647
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 22.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 759,229 2018-09-30 2018 Q3 10-Q 2018-11-08 0001387131-18-005976
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 152,478 2014-12-31 2015 FY 10-K 2016-02-26 0001387131-16-004361
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 550,757 2019-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 11.73M 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 5.00M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056434
us-gaap DeferredRevenue Deferred Revenue USD 522,613 2014-12-31 2015 FY 10-K 2016-02-26 0001387131-16-004361
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 124,271 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-07 0001387131-14-001673
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 19.71M 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 172.34M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 186,000 2024-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 154.28M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 12.80M 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 59,000 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DeferredTaxAssetsOtherLossCarryforwards Deferred Tax Assets, Other Loss Carryforwards USD 180.52M 2019-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 1.02M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 8.59M 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 19.24M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 621,000 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 172.34M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 500,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.04 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap DepositContractsAssets Deposit Contracts, Assets USD 21.60M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 334,866 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap Depreciation Depreciation USD 313,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 286,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 286,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap DepreciationNonproduction Depreciation, Nonproduction USD 285,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.75M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap DirectTaxesAndLicensesCosts Cost, Direct Tax and License USD 20.00M 2019-01-01 2019-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD 705,668 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax USD -46,591 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net USD 344,000 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 33.55M 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap DisposalGroupIncludingDiscontinuedOperationConsideration Disposal Group, Including Discontinued Operation, Consideration USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss Disposal Group, Including Discontinued Operation, Operating Income (Loss) USD -27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherIncome Disposal Group, Including Discontinued Operation, Other Income USD 110,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD -705,668 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap DividendsPayableAmountPerShare Dividends Payable, Amount Per Share USD/shares 0.4 2015-03-31 2015 Q1 10-Q 2015-05-07 0001387131-15-001534
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 41,359 2013-09-30 2013 Q3 10-Q 2013-11-05 0001387131-13-004064
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 41,359 2015-03-31 2015 Q1 10-Q 2015-05-07 0001387131-15-001534
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 249,981 2014-12-31 2015 FY 10-K 2016-02-26 0001387131-16-004361
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -5.69 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001564590-22-020440
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 1.527 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.483 2024-01-01 2024-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 908,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.242 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.286 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 505,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 1,000 2025-03-31 2025 Q1 10-Q 2025-05-13 0001213900-25-042697
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 9.99M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 28,000 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 100,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap FinancingInterestExpense Financing Interest Expense USD 5,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 2.71M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 383,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 97,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.38M 2026-06-30 2026 Q2 10-Q 2026-08-11 0001213900-26-087768
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 383,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 383,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 384,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 6.17M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 107,094 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 58,605 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 200,029 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 143.38M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -8.38M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap Goodwill Goodwill USD 288,443 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 1.26M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109381
us-gaap GrossProfit Gross Profit USD 1.30M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ImpairmentLossesRelatedToRealEstatePartnerships Impairment Losses Related to Real Estate Partnerships USD 1.27M 2024-01-01 2024-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 59,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 584,509 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001387131-20-009695
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 1.26M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109381
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 768,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -653,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 768,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -181,234 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares 0.01 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares 0.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares 0.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD -3.24M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0.04 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeTaxesPaid Income Taxes Paid USD 36,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -32,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -996,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001213900-26-036515
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -137,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1.13M 2024-01-01 2024-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -8.74M 2024-01-01 2024-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -186,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 5,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -3.04M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.21M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 369,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -522,613 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-23 0001387131-18-000776
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 59,375 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001387131-18-005976
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -848,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -817,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -5.42M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-07 0001387131-20-007144
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1.13M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -24,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -2.02M 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -3.81M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001387131-20-009695
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 120,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -1,997 2011-01-01 2011-06-30 2011 Q2 10-Q 2011-08-15 0001387131-11-001704
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 20,420 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 10,686 2014-01-01 2014-06-30 2015 Q2 10-Q 2015-08-07 0001387131-15-002352
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 14,036 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-04 0001387131-16-007716
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 755,748 2013-12-31 2014 Q3 10-Q 2014-11-07 0001387131-14-003647
us-gaap IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit Indefinite-lived Intangible Assets, Written off Related to Sale of Business Unit USD 176,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 6.29M 2025-06-30 2025 Q2 10-Q 2025-08-12 0001213900-25-075003
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 3.46M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 7,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109381
us-gaap InterestExpense Interest Expense USD 300,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap InterestExpenseBorrowings Interest Expense, Borrowings USD 3.98M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap InterestExpenseDebt Interest Expense, Debt USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap InterestIncomeOther Interest Income, Other USD 150,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 12.45M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001387131-19-008469
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 13.54M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap InterestPayableCurrent Interest Payable, Current USD 3.06M 2022-06-30 2022 Q2 10-Q 2022-08-15 0001564590-22-029490
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 150,068 2012-12-31 2013 FY 10-K 2014-03-05 0001387131-14-000771
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 4.54M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap InventoryNet Inventory, Net USD 6.70M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 14,036 2016-12-31 2017 FY 10-K 2018-02-23 0001387131-18-000776
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 1.95M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 5.74M 2020-09-30 2020 Q3 10-Q 2020-11-09 0001387131-20-009695
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 218,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap InventoryWriteDown Inventory Write-down USD 5.70M 2020-07-01 2020-09-30 2021 FY 10-K 2022-03-23 0001564590-22-011525
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 187,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 7,699 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 916,262 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-07 0001387131-15-002352
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.07M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap LegalFees Legal Fees USD 52,016 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.31M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 993,000 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.42M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 992,000 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.67M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.63M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.59M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 610,675 2020-09-30 2020 Q3 10-Q 2020-11-09 0001387131-20-009695
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.21M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap Liabilities Liabilities USD 10.31M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 37.93M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap LiabilitiesCurrent Liabilities, Current USD 5.25M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 246.37M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 3.69M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 6.00M 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 299,220 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap LineOfCreditFacilityInterestRateAtPeriodEnd Line of Credit Facility, Interest Rate at Period End pure 0.03 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 300,000 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 100,000 2013-03-31 2013 Q1 10-Q 2013-05-10 0001387131-13-001675
us-gaap LongTermDebt Long-term Debt USD 188.27M 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 188.27M 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 5.00M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056434
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five USD 0 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD 41.25M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD 41.25M 2021-03-31 2021 Q3 10-Q 2021-11-12 0001564590-21-056434
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD 41.25M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056434
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 3.59M 2012-12-31 2013 FY 10-K 2014-03-05 0001387131-14-000771
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2021-12-31 2021 FY 10-K 2022-03-23 0001564590-22-011525
us-gaap NetCashProvidedByUsedInDiscontinuedOperations Net Cash Provided by (Used in) Discontinued Operations USD -27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 3.15M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 1.15M 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -212,000 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145064
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -355,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -8.70M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145064
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 2.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -569,000 2025-01-01 2025-12-31 DEF 14A 2026-11-20 0001213900-26-122695
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) USD 31,000 2017-12-31 2017 FY 10-K 2018-02-23 0001387131-18-000776
us-gaap NoncashOrPartNoncashAcquisitionAccountsReceivableAcquired1 Noncash or Part Noncash Acquisition, Accounts Receivable Acquired USD 5,793 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 231,580 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 6,748 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD 2,844 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Other Liabilities Assumed USD -18,448 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD -461,272 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap NotesAndLoansPayableCurrent Notes and Loans Payable, Current USD 2.15M 2011-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap NotesIssued1 Notes Issued USD 15,123 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap NotesPayable Notes Payable USD 3.10M 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 200,000 2011-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap OperatingExpenses Operating Expenses USD 4.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -2.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.31M 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.40M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap OperatingLeaseLeaseIncomeLeasePayments Operating Lease, Lease Income, Lease Payments USD 1.51M 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.10M 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.21M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.41M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.59M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 704,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 13.30M 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 270,073 2018-09-30 2018 Q3 10-Q 2018-11-08 0001387131-18-005976
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 943,127 2017-09-30 2017 Q3 10-Q 2017-11-07 0001387131-17-005313
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 943,127 2018-09-30 2018 Q3 10-Q 2018-11-08 0001387131-18-005976
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.11M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001387131-18-005976
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.09M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001387131-18-005976
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 698,421 2016-09-30 2016 Q3 10-Q 2016-11-04 0001387131-16-007716
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 121,698 2015-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.07M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 41,613 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-28 0001387131-17-001111
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.083 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 579.00M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 348,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OtherAmortizationOfDeferredCharges Amortization of Other Deferred Charges USD 1.50M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-07 0001387131-20-007144
us-gaap OtherAssets Other Assets USD 3.64M 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap OtherAssetsCurrent Other Assets, Current USD 755,152 2015-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 253,121 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 370,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap OtherIncome Other Income USD 6,392 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-27 0001387131-12-000862
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 6.93M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 849,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap OtherNoncashExpense Other Noncash Expense USD 78,864 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 2,944 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001387131-16-004361
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 407,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145064
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 869,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 587,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001213900-25-109381
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 2,486 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 379,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 2.50M 2022-01-01 2022-09-30 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap PaymentsForDeposits Payments for Deposits USD 103,737 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-05 0001387131-14-000771
us-gaap PaymentsForDerivativeInstrumentFinancingActivities Payments for Derivative Instrument, Financing Activities USD 2.97M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap PaymentsForProceedsFromOtherDeposits Payments for (Proceeds from) Other Deposits USD -10,686 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap PaymentsForRepurchaseOfPreferredStockAndPreferenceStock Payments for Repurchase of Preferred Stock and Preference Stock USD 38.66M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 1.62M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 140.00M 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 355,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 14,036 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-07 0001387131-17-005313
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 21,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2023-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145064
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145064
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-03-31 2023 Q1 10-Q 2023-05-15 0001193125-23-145064
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2022-06-30 2022 Q2 10-Q 2022-08-15 0001564590-22-029490
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 1.63M 2014-03-31 2014 Q1 10-Q 2014-05-07 0001387131-14-001673
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.56M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2,997 2013-03-31 2013 Q1 10-Q 2013-05-10 0001387131-13-001675
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 759,229 2018-06-30 2018 Q2 10-Q 2018-07-30 0001387131-18-003401
us-gaap PrepaidExpenseOtherNoncurrent Prepaid Expense Other, Noncurrent USD 193,347 2015-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap PrepaidInsurance Prepaid Insurance USD 161,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap PrepaidRent Prepaid Rent USD 429,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 400,000 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-10 0001387131-13-001675
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 3.32M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 142.63M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 3.15M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 75.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001387131-19-001471
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 75.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 21.68M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 16.25M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 400 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 707,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-05 0001387131-14-000771
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 50.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-23 0001564590-22-011525
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 8.70M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 200.00M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001387131-19-008469
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 2.00M 2023-11-15 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD -500,000 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-05 0001387131-13-004064
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD -50,000 2012-01-01 2012-09-30 2013 Q3 10-Q 2013-11-05 0001387131-13-004064
us-gaap ProceedsFromRoyaltiesReceived Proceeds from Royalties Received USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap ProceedsFromSaleOfInterestInCorporateUnit Proceeds from Sale of Interest in Corporate Unit USD 707,000 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 100,000 2013-01-01 2013-03-31 2014 Q1 10-Q 2014-05-07 0001387131-14-001673
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 3.80M 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-27 0001387131-19-001471
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.52M 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 78,000 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap PropertyPlantAndEquipmentOwnedGross Property, Plant, and Equipment, Owned, Gross USD 220,518 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 542,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 974,000 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-08-09 0001387131-19-005935
us-gaap RentalIncomeNonoperating Rental Income, Nonoperating USD 1.85M 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap RepaymentsOfDebt Repayments of Debt USD 219.43M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 81.66M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 4.69M 2013-01-01 2013-12-31 2015 FY 10-K 2016-02-26 0001387131-16-004361
us-gaap RepaymentsOfOtherLongTermDebt Repayments of Other Long-term Debt USD 81.66M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 200,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001387131-15-000875
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.09M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 11.25M 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 5.40M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap RestructuringCharges Restructuring Charges USD 9.47M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap RestructuringReserve Restructuring Reserve USD 2.46M 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -951.65M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 800,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap Revenues Revenues USD 724,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055081
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 999,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-23 0001564590-22-011525
us-gaap RoyaltyExpense Royalty Expense USD 257,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 1.29M 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 2.15 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap SalesReturnsAndAllowancesGoods Sales Returns and Allowances, Goods (Deprecated 2018-01-31) USD 27,168 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 7.54M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-07-30 0001387131-18-003401
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 61.70M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037666
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 3.04M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001213900-25-075003
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.09 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001387131-17-001111
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 2.58 2017-09-30 2017 Q3 10-Q 2017-11-07 0001387131-17-005313
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.694 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.448 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.408 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.029 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.022 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.007 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 435,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 1.24M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001387131-19-008469
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 13.78M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001387131-19-008469
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2022-12-31 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 64,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 264.02 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 61,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 9,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 3.01 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 4,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 480,000 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.84 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001387131-19-008469
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 3.92M 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 3.03 2014-09-30 2014 Q3 10-Q 2014-11-07 0001387131-14-003647
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2022-12-31 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 63,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 264.14 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 130.71M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.06 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.5 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 217.57 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 94.99 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 60.5 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap SharePrice Share Price USD/shares 1.7 2013-09-30 2013 Q3 10-Q 2013-11-05 0001387131-13-004064
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1.186 2021-11-08 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap ShortTermNonBankLoansAndNotesPayable Short-term Non-bank Loans and Notes Payable USD 2.10M 2012-09-30 2012 Q3 10-Q 2012-11-13 0001387131-12-003625
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 75,000 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-01 0001213900-26-037918
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 27.62M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 54.70M 2013-12-31 2013 FY 10-K 2014-03-05 0001387131-14-000771
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.02 2022-05-06 2023 Q3 10-Q 2023-11-14 0001193125-23-277143
us-gaap StockIssued1 Stock Issued USD -50,000 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-07 0001387131-11-002429
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 365,583 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 1.95M 2013-04-01 2013-04-30 2013 Q1 10-Q 2013-05-10 0001387131-13-001675
us-gaap StockIssuedDuringPeriodSharesIssuedForNoncashConsideration Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) shares 1.05M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 8.56M 2014-08-03 2014-08-04 2014 Q3 10-Q 2014-11-07 0001387131-14-003647
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 358,400 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-07 0001387131-15-001534
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 50,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-07 0001387131-14-003647
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 181,000 2014-01-01 2014-09-30 2015 Q3 10-Q 2015-11-05 0001387131-15-003188
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 14,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 8.50M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-12 0001387131-13-000737
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.15M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.15M 2023-04-01 2023-06-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 3.00M 2022-12-30 2026 Q1 10-Q 2026-05-12 0001213900-26-055081
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 1,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003442
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 11.57M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0001213900-24-028003
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 44,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 3.00M 2022-12-30 2024 Q2 10-Q 2024-08-12 0001213900-24-067771
us-gaap SubleaseIncome Sublease Income USD 1.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Incomplete Accounting, Provisional Income Tax Expense (Benefit) (Deprecated 2020-01-31) USD 46.70M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-24 0001387131-20-002086
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount Unrecorded Unconditional Purchase Obligation USD 2.60M 2018-12-31 2018 FY 10-K 2019-02-27 0001387131-19-001471
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 49.55M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140
us-gaap VariableLeaseCost Variable Lease, Cost USD 226,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-09 0001387131-20-009695
us-gaap VariableLeasePayment Variable Lease, Payment USD 700,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-07 0001564590-23-005514
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 6.53M 2020-09-30 2020 Q3 10-Q 2020-11-09 0001387131-20-009695
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 11.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 8.61M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001564590-22-020440
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 11.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001213900-26-119697
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 275,379 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001387131-21-003140

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →